175 related articles for article (PubMed ID: 7676713)
21. Intrahepatic stones associated with cholangiocarcinoma.
Chen MF; Jan YY; Wang CS; Jeng LB; Hwang TL; Chen SC
Am J Gastroenterol; 1989 Apr; 84(4):391-5. PubMed ID: 2539010
[TBL] [Abstract][Full Text] [Related]
22. "Late development of cholangiocarcinoma after the treatment of hepatolithiasis".
Khan TF
J Am Coll Surg; 1994 Jul; 179(1):127-8. PubMed ID: 8019717
[No Abstract] [Full Text] [Related]
23. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.
Cheon YK; Cho YD; Moon JH; Lee JS; Shim CS
Surgery; 2009 Nov; 146(5):843-53. PubMed ID: 19744434
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
25. Malignancy associated with hepatolithiasis.
Chu KM; Lo CM; Liu CL; Fan ST
Hepatogastroenterology; 1997; 44(14):352-7. PubMed ID: 9164501
[TBL] [Abstract][Full Text] [Related]
26. Down stream involvement of the bile duct in hepatolithiasis.
Lu S; Yan L; Rao L; Xia T; Gou J; Zhang S; Lei S
Chin Med J (Engl); 2002 Jan; 115(1):62-4. PubMed ID: 11930661
[TBL] [Abstract][Full Text] [Related]
27. [Cholangiocarcinoma--bile ducts cancer].
Dubaniewicz A; Dubaniewicz A
Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
[TBL] [Abstract][Full Text] [Related]
28. Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.
Perdue DG; Cass OW; Milla C; Dunitz J; Jessurun J; Sharp HL; Schwarzenberg SJ
Dig Dis Sci; 2007 Oct; 52(10):2638-42. PubMed ID: 17443409
[No Abstract] [Full Text] [Related]
29. Intrahepatic cholangiocarcinoma associated with hepatolithiasis.
Sato M; Watanabe Y; Ueda S; Ohno J; Kashu Y; Nezu K; Kawachi K
Hepatogastroenterology; 1998; 45(19):137-44. PubMed ID: 9496503
[TBL] [Abstract][Full Text] [Related]
30. Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma.
Chen MF; Jan YY; Hwang TL; Jeng LB; Yeh TS
Dig Dis Sci; 2000 Feb; 45(2):312-6. PubMed ID: 10711444
[TBL] [Abstract][Full Text] [Related]
31. Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma.
Nakanuma Y; Terada T; Tanaka Y; Ohta G
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):45-58. PubMed ID: 2986349
[TBL] [Abstract][Full Text] [Related]
32. Biliary cystadenocarcinoma associated with atrophy of the left hepatic lobe and hepatolithiasis mimicking intrahepatic cholangiocarcinoma: a case report.
Tseng CA; Pan YS; Chen CY; Liu CS; Wu DC; Wang WM; Jan CM
Kaohsiung J Med Sci; 2004 Apr; 20(4):198-203. PubMed ID: 15191223
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
Lee KT; Liu TS
World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
[TBL] [Abstract][Full Text] [Related]
34. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease.
Sheen-Chen SM; Chou FF; Eng HL
J Surg Oncol; 1991 Jun; 47(2):131-5. PubMed ID: 1648151
[TBL] [Abstract][Full Text] [Related]
36. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma.
Kubo S; Kinoshita M; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Hamano G; Ito T; Abue M; Aoki M; Nakagawa K; Unno M; Hijioka S; Fujiyoshi T; Shimizu Y; Mizuguchi T; Shirabe K; Nishie A; Oda Y; Takenaka K; Kobarai T; Hisano T; Saiura A; Numao H; Toda M; Kuwae Y; Nakanuma Y; Endo G
J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):809-17. PubMed ID: 25088751
[TBL] [Abstract][Full Text] [Related]
38. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma].
Zong D; Zeng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348
[TBL] [Abstract][Full Text] [Related]
39. Hepatolithiasis associated with cholangiocarcinoma.
Su CH; Shyr YM; Lui WY; P'Eng FK
Br J Surg; 1997 Jul; 84(7):969-73. PubMed ID: 9240138
[TBL] [Abstract][Full Text] [Related]
40. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis.
Ohta T; Nagakawa T; Ueda N; Nakamura T; Akiyama T; Ueno K; Miyazaki I
Cancer; 1991 Nov; 68(10):2217-23. PubMed ID: 1655206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
